Archive for November 2025

HOUSTON, Nov. 26, 2025 /PRNewswire/ — Nutex Health Inc. (“Nutex Health” or the “Company”) (NASDAQ: NUTX), is aware of a short seller report issued on November 25, 2025 by Capybara Research. Based on publicly available information, Capybara Research as an entity seems not to exist. In the past, lawsuits filed against Capybara by other victims…

HOUSTON, Nov. 24, 2025 /PRNewswire/ — Nutex Health Inc. (“Nutex Health” or the “Company”) (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 25 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physician networks, today announced the reopening of Red River ER & Hospital in Sherman, Texas.…

Total revenue of $723.6 million for the first nine months of 2025 versus $222.3 million for the first nine months of 2024, an increase of 225.5% Net income attributable to Nutex Health Inc. of $59.0 million for the first nine months of 2025 versus net loss of $9.5 million for the first nine months of…

Total revenue of $455.8 million for the first half of 2025 versus $143.5 million for the first half of 2024, an increase of 217.5% Net income attributable to Nutex Health Inc. of $3.5 million for the first half of 2025 versus net loss of $0.7 million for the first half of 2024, an increase of…

Total revenue of $211.8 million for Q1 2025 versus $67.5 million for Q1 2024, an increase of 214.0% Net income attributable to Nutex Health Inc. of $21.2 million for Q1 2025 versus net loss of $0.4 million for Q1 2024, an increase of $21.6 million. Diluted income per share of $3.33 for Q1 2025 versus…

FULL YEAR 2024 HIGHLIGHTS: Total revenue of $479.9 million for the year 2024 versus $247.6 million for the year 2023, an increase of 93.8% Net income attributable to Nutex Health Inc. of $52.1 million for 2024 versus net loss of $45.8 million for 2023 Diluted income per share of $9.69 for 2024 versus a loss…